The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning for anyone taking Ozempic, Wegovy, Rybelsus, or Mounjaro. The health body made the appeal on social media for anyone ...
3hon MSN
Health body issues 'severe reaction' alert for anyone taking Ozempic, Wegovy, Rybelsus, or Mounjaro
It made the call for anyone suffering from a 'severe reaction' to GLP-1 medicine. According to the Government website, ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning for anyone taking Ozempic, Wegovy, Rybelsus, or Mounjaro ...
It made the call for anyone suffering from a 'severe reaction' to GLP-1 medicine. According to the Government website, ...
HONG KONG, Nov. 3, 2025 /PRNewswire/ -- Leading global healthcare company Novo Nordisk announces the launch of Wegovy® in Hong Kong, now available at private clinics and selected pharmacies.
ScienceAlert on MSN
US Obesity Rates Have Dropped, And GLP-1 Drugs May Explain Why
New survey data shows 37 percent of US adults are currently classed as obese, down from a record high of 39.9 percent in 2022 ...
Molecule is claimed to be made from "natural ingredients" such as dandelion root and fennel seed, but investigations tell a different story ...
Viking Therapeutics is mispriced due to the successful but misunderstood clinical results of their oral GLP-1 treatment. Read ...
27mon MSN
Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech
The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors ...
24/7 Wall St. on MSN
Viking Therapeutics Could Be Pharma’s Next Big Buyout Target
Quick Read GLP-1 market growth is fueling Viking Therapeutics‘ (VKTX) momentum with VK2735 in Phase 3 and VK2809’s NASH ...
Pfizer has filed a lawsuit against Novo Nordisk and Metsera in an attempt to force through its takeover of the weight-loss drug developer and prevent Novo Nordisk from taking its rival bid forward.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results